IQP-PO-101

IQP-PO-101 is an oral product developed primarily for the regulation of bowel movement frequency, targeting individuals with constipation or irregular bowel movements. It has undergone clinical evaluation for its safety and efficacy in increasing bowel movement frequency in individuals with 2–4 bowel movements per week and symptoms consistent with idiopathic constipation, such as excessive straining and hard stools. The specific mechanism of action and composition have not been disclosed in trial summaries, and 'IQP-PO' suggests it is part of a series of proprietary products developed by InQpharm Group. No pharmaceutical mechanism (e.g., receptor target) is specified in public sources, and it is likely developed as a dietary supplement or medical food/device rather than as a classic pharmaceutical[2][3].

Brand names

IQP-PO-101IQP-PO101IQP-PO 101

Other names

IQP-PO-101IQP-PO101IQP-PO 101